Trimethoprim–Sulfamethoxazole versus Placebo for Uncomplicated Skin Abscess

2016224 citationsJournal Articlebronze Open Access

Authors

David A. Talan · Olive View-UCLA Medical Center

William R. Mower

Anusha Krishnadasan · Olive View-UCLA Medical Center

Fredrick M. Abrahamian · Olive View-UCLA Medical Center

Frank LoVecchio · University of Arizona

David J. Karras · Temple University

Mark T. Steele · University of Missouri

Abstract

In settings in which MRSA was prevalent, trimethoprim-sulfamethoxazole treatment resulted in a higher cure rate among patients with a drained cutaneous abscess than placebo. (Funded by the National Institute of Allergy and Infectious Diseases; ClinicalTrials.gov number, NCT00729937.).

Topics & Keywords

Streptococcal Infections and Treatments Antimicrobial Resistance in Staphylococcus Infectious Diseases and Tuberculosis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 374, Issue 9, pp. 823-832

DOI: 10.1056/nejmoa1507476

Field-Weighted Citation Impact: 35.41